Sales of Dupixent Boost Sanofi's Q1 Profit.

Published Date: 29 Apr 2023

On Thursday, the French pharmaceutical company Sanofi reported earnings that were higher than anticipated due to ongoing success with the anti-inflammatory drug Dupixent, which more than offset declining sales of a well-known MS medication.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

3.

Rural-urban disparities seen in cervical cancer

4.

Obesity linked to subsequent neoplasms in childhood cancer survivors

5.

New policy review highlights the importance of health-related quality of life in advanced cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot